So, an elevated LDL cholesterol level is a major risk factor for heart disease and stroke. While lowering LDL cholesterol levels with statin drugs significantly reduces cardiac risk, reducing LDL ...
HOFH is an inherited disease that causes dangerously high levels of low-density lipoprotein cholesterol (LDL-C ... 12 years and older with HoFH. The drug’s label was later expanded in 2023 ...
Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.
Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...
If it makes it through development, VERVE-101 could provide a one-off alternative to a lengthening list ... PCSK9 drug MK-0616 will find a role, as it can be dosed alongside current cholesterol ...